Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes

scientific article published on 20 December 2012

Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JPEDS.2012.11.017
P932PMC publication ID3610780
P698PubMed publication ID23260099

P50authorMelanie G CreeQ60345817
P2093author name stringMark Brown
Laura Z Fenton
Jacob E Friedman
Zhaoxing Pan
Ann Scherzinger
Linda A Barbour
Meredith Alston
Regina Reynolds
David E Brumbaugh
Camille Hoffman
Phillip Tearse
P2860cites workPrevalence and trends in obesity among US adults, 1999-2008Q29547759
Physical water compartments: a revised concept of perinatal body water physiologyQ30990401
Cord blood lipid profile and associated factors: baseline data of a birth cohort studyQ31133140
Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a reviewQ31147355
Maternal overweight programs insulin and adiponectin signaling in the offspring.Q33874488
Lipid metabolism in the fetus and the newbornQ33950662
Offspring of mothers fed a high fat diet display hepatic cell cycle inhibition and associated changes in gene expression and DNA methylation.Q33968085
Criteria for screening tests for gestational diabetesQ34057052
Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitusQ34399314
Magnetic resonance imaging of total body fat.Q34478709
Long-term impact of neonatal breastfeeding on childhood adiposity and fat distribution among children exposed to diabetes in uteroQ34583303
Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging.Q34987278
Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: metabolic determinants of fetal growthQ35225493
Pediatric obesity phenotyping by magnetic resonance methodsQ35846444
Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) StudyQ35879112
Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus.Q36842095
Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primatesQ37073698
Obesity and the placenta: A consideration of nutrient exchange mechanisms in relation to aberrant fetal growth.Q37804549
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general populationQ39693472
Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in miceQ43088513
Maternal triglyceride levels and newborn weight in pregnant women with normal glucose toleranceQ45192290
Maternal diabetes and perinatal programmingQ46333328
Independent effect of visceral adipose tissue on metabolic syndrome in obese adolescentsQ46584914
Nonalcoholic fatty liver disease and carotid atherosclerosis in childrenQ46689926
Weight gain recommendations in pregnancy and the obesity epidemicQ47579331
Differential growth of fetal tissues during the second half of pregnancyQ48811470
Body composition from birth to 4.5 months in infants born to non-obese women.Q51574558
Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression.Q51610482
Resistance to high-fat diet in the female progeny of obese mice fed a control diet during the periconceptual, gestation, and lactation periods.Q51773758
Role of lipids and fatty acids in macrosomic offspring of diabetic pregnancy.Q51972536
I. Using the Bland–Altman method to measure agreement with repeated measuresQ60706382
The Human Visceral Fat Depot Has a Unique Inflammatory ProfileQ61774862
Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadaversQ72879987
Distribution of adipose tissue in the newbornQ75185464
Fast and reproducible method for the direct quantitation of adipose tissue in newborn infantsQ77728136
Body-composition assessment in infancy: air-displacement plethysmography compared with a reference 4-compartment modelQ79512510
The influence of maternal body mass index on infant adiposity and hepatic lipid contentQ84237518
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectobesityQ12174
gestational diabetesQ126691
P304page(s)930-6.e1
P577publication date2012-12-20
P1433published inThe Journal of PediatricsQ7743611
P1476titleIntrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes
P478volume162

Reverse relations

cites work (P2860)
Q89360925A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes
Q60301299A long-term maternal diet transition from high-fat diet to normal fat diet during pre-pregnancy avoids adipose tissue inflammation in next generation
Q30386847Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease.
Q60923925Childhood Fructoholism and Fructoholic Liver Disease
Q100467626Developmental Programming of NAFLD by Parental Obesity
Q41459686Developmental Programming of Nonalcoholic Fatty Liver Disease: The Effect of Early Life Nutrition on Susceptibility and Disease Severity in Later Life.
Q57786921Developmental Programming of Obesity and Diabetes in Mouse, Monkey, and Man in 2018: Where Are We Headed?
Q30241940Developmental origins of NAFLD: a womb with a clue
Q33844787Developmental origins of nonalcoholic fatty liver disease
Q37149656Developmental programming of pediatric nonalcoholic fatty liver disease: redefining the"first hit".
Q37600179Diabetes in pregnancy and infant adiposity: systematic review and meta-analysis.
Q47868552Early Microbes Modify Immune System Development and Metabolic Homeostasis-The "Restaurant" Hypothesis Revisited
Q36231960Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice
Q37737481Early infant adipose deposition is positively associated with the n-6 to n-3 fatty acid ratio in human milk independent of maternal BMI.
Q33959776Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates
Q39006023Early life programming and the risk of non-alcoholic fatty liver disease
Q33938664Effect of maternal obesity with and without gestational diabetes on offspring subcutaneous and preperitoneal adipose tissue development from birth up to year-1.
Q36355537Emerging Technologies and their Applications in Lipid Compartment Measurement
Q91929324Excessive early-life cholesterol exposure may have later-life consequences for nonalcoholic fatty liver disease
Q47766573Fetal Overnutrition and Adolescent Hepatic Fat Fraction: the Exploring Perinatal Outcomes in Children Study.
Q90004538Free-breathing 3-D quantification of infant body composition and hepatic fat using a stack-of-radial magnetic resonance imaging technique
Q50147806Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.
Q38170410Gestational diabetes mellitus and cardiovascular risk after pregnancy.
Q92759281Implications of Nonalcoholic Fatty Liver Disease on Pregnancy and Maternal and Child Outcomes
Q36422562Increased placental fatty acid transporter 6 and binding protein 3 expression and fetal liver lipid accumulation in a mouse model of obesity in pregnancy
Q38352166Influence of maternal overnutrition and gestational diabetes on the programming of metabolic health outcomes in the offspring: experimental evidence
Q92567501Liver Diseases in the Perinatal Period: Interactions Between Mother and Infant
Q40263336Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children.
Q90399714Maternal Fat-1 Transgene Protects Offspring from Excess Weight Gain, Oxidative Stress, and Reduced Fatty Acid Oxidation in Response to High-Fat Diet
Q91592451Maternal Lipids and Fetal Overgrowth: Making Fat from Fat
Q88621894Maternal Non-glycemic Contributors to Fetal Growth in Obesity and Gestational Diabetes: Spotlight on Lipids
Q91556029Maternal body mass index, gestational weight gain, and childhood abdominal, pericardial, and liver fat assessed by magnetic resonance imaging
Q45810128Maternal obesity alters fatty acid oxidation, AMPK activity, and associated DNA methylation in mesenchymal stem cells from human infants
Q38413839Maternal obesity characterized by gestational diabetes increases the susceptibility of rat offspring to hepatic steatosis via a disrupted liver metabolome.
Q35050191Maternal obesity influences the relationship between location of neonate fat mass and total fat mass
Q37118107Maternal sodium butyrate supplement elevates the lipolysis in adipose tissue and leads to lipid accumulation in offspring liver of weaning-age rats
Q90213353Metabolic Culprits in Obese Pregnancies and Gestational Diabetes Mellitus: Big Babies, Big Twists, Big Picture : The 2018 Norbert Freinkel Award Lecture
Q64987782Mice exposed to maternal androgen excess and diet-induced obesity have altered phosphorylation of catechol-O-methyltransferase in the placenta and fetal liver.
Q35914082Microbial transmission from mothers with obesity or diabetes to infants: an innovative opportunity to interrupt a vicious cycle
Q51287371Non-Alcoholic Fatty Liver Disease in Early Pregnancy Predicts Dysglycemia in Mid-Pregnancy: Prospective Study.
Q27006992Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?
Q33789868Non-alcoholic fatty liver disease: An expanded review
Q57802817Normalizing adiponectin levels in obese pregnant mice prevents adverse metabolic outcomes in offspring
Q53693108Nutrition therapy within and beyond gestational diabetes.
Q50204614Obesity in Pregnancy: Optimizing Outcomes for Mom and Baby
Q37125762Obesity, maternal smoking and SHBG in neonates
Q35019764On the origin of pediatric nonalcoholic Fatty liver disease.
Q36115938Optimizing Weight for Maternal and Infant Health - Tenable, or Too Late?
Q33831717Pediatric Non-Alcoholic Fatty Liver Disease
Q89580537Physical exercise and liver "fitness": Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease
Q89185215Postprandial Triglycerides Predict Newborn Fat More Strongly than Glucose in Women with Obesity in Early Pregnancy
Q49980187Quantification of fetal organ volume and fat deposition following in utero exposure to maternal Western Diet using MRI.
Q50942572Radiographic depiction of intra-abdominal fat in newborns: a marker of infants born to diabetic mothers.
Q92513941Reduced size at birth and persisting reductions in adiposity in recent, compared with earlier, cohorts of infants born to mothers with gestational diabetes mellitus
Q99587158Seeing the fetus from a DOHaD perspective: discussion paper from the advanced imaging techniques of DOHaD applications workshop held at the 2019 DOHaD World Congress
Q38589455Striking differences in estimates of infant adiposity by new and old DXA software, PEAPOD and skin-folds at 2 weeks and 1 year of life
Q58548367Switching obese mothers to a healthy diet improves fetal hypoxemia, hepatic metabolites, and lipotoxicity in non-human primates
Q92712205The Liver in Children With Metabolic Syndrome
Q36792850The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease.
Q58726261The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD)
Q58115572The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD
Q50318508The role of NAFLD in cardiometabolic disease: an update.
Q92298443Transgenerational impact of maternal obesogenic diet on offspring bile acid homeostasis and nonalcoholic fatty liver disease
Q34795140Transgenic increase in N-3/n-6 Fatty Acid ratio reduces maternal obesity-associated inflammation and limits adverse developmental programming in mice
Q91406319Understanding susceptibility and targeting treatment in non-alcoholic fatty liver disease in children; moving the fulcrum

Search more.